Currently, major driving factors for Bronchiolitis Obliterans Syndrome market include development of potential therapies such as Zambon's Phase III asset, Liposomal cyclosporine A, under clinical
Currently, major driving factors for Bronchiolitis Obliterans Syndrome market include development of potential therapies such as Zambon s Phase III asset,.
Currently, major driving factors for Bronchiolitis Obliterans Syndrome market include development of potential therapies such as Zambon s Phase III asset,.
N-Acetylcysteine Market is Anticipated to Reach Around USD 2 2 BN in 2027 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
The global N-Acetylcysteine market generated revenue of around USD 1032.6 million in 2020 and is anticipated to grow at a CAGR of over 21.3% during the forecast period from 2021 to 2027 to reach around USD 2200 million in 2027. N-Acetylcysteine is a byproduct obtained during the production of glutathione. N-acetylcysteine is the medication used for treating medical conditions like cystic fibrosis and asthma. After inhalation, it helps in thinning of mucus. It also helps in the reduction of inflammation. It is also useful for treating dry eye, acetaminophen poisoning, and flu among others. Key Trends in Global N-Acetylcysteine Market Increasing demand for…